Association of metabolic alterations with prognostic factors in malignant breast neoplasms

Authors

  • Rosekeila Simões Nomelini Universidade Federal do Triângulo Mineiro
  • Eddie Fernando Candido Murta Universidade Federal do Triângulo Mineiro
  • Fabíola Souza de Oliveira Flores Navarro Santa Casa de Misericórdia
  • Ana Luísa Batista Pena Hospital Federal da Lagoa
  • Beatriz Martins Tavares Murta Universidade Federal do Triângulo Mineiro

Keywords:

Breast neoplasms, Metabolic diseases, Prognosis, Cholesterol, Triglycerides

Abstract

Objectives: There are few studies in the literature correlating metabolic alterations with prognostic factors in breast cancer. The aims of this study were to evaluate serum levels of total cholesterol, HDL, LDL, triglycerides and fasting glucose, weight, body mass index and blood pressure, and relate them to prognostic factors (stage, lymph node involvement, histological grade, estrogen and progesterone receptors, ki-67 and Her2/neu) in patients with breast cancer. Methods: A retrospective study was conducted in Mastology Service of the Discipline of Gynecology and Obstetrics/Oncologycal Research Institute (IPON) of the Universidade Federal do Triângulo Mineiro (UFTM). We evaluated 100 patients with breast cancer treated at Mastology Clinic (surgical and/or clinical treatment). Serum levels of total cholesterol, HDL, LDL, triglycerides and fasting glucose, weight, body mass index, blood pressure, staging, lymph node involvement, histological grade and immunohistochemical panel (estrogen and progesterone receptors, ki-67 and HER-2/neu) were recorded. Data were expressed as the mean ± standard deviation, and the values were compared by using Student’s t-test. P-values less than 0.05 were considered statistically significant. Results: Histological grades 1 and 2 were significantly correlated with higher HDL serum levels (p=0.02). Higher levels of triglycerides were found more frequently in grade 3, and highest weight was related to Ki-67 positive, but only with a trend towards significance (p=0.07). Conclusion: HDL can be related to prognosis in breast cancer.

Downloads

Download data is not yet available.

Author Biographies

Rosekeila Simões Nomelini, Universidade Federal do Triângulo Mineiro

Department of Gynecology and Obstetrics/IPON of the UFTM – Uberaba (MG), Brazil.

Eddie Fernando Candido Murta, Universidade Federal do Triângulo Mineiro

Department of Gynecology and Obstetrics/IPON of the UFTM – Uberaba (MG), Brazil.

Fabíola Souza de Oliveira Flores Navarro, Santa Casa de Misericórdia

Santa Casa de Misericórdia – São José do Rio Preto (SP), Brazil.

Ana Luísa Batista Pena, Hospital Federal da Lagoa

Hospital Federal da Lagoa – Rio de Janeiro (RJ), Brazil.

Beatriz Martins Tavares Murta, Universidade Federal do Triângulo Mineiro

Associated Professor of Pharmacology/IPON of the UFTM – Uberaba (MG), Brazil.

Downloads

Published

2015-07-30

How to Cite

Nomelini, R. S., Murta, E. F. C., Navarro, F. S. de O. F., Pena, A. L. B., & Murta, B. M. T. (2015). Association of metabolic alterations with prognostic factors in malignant breast neoplasms. Revista Brasileira De Mastologia, 25(3), 79–83. Retrieved from https://revistamastology.emnuvens.com.br/rbm/article/view/178

Issue

Section

Original Article